Peptide therapeutics company targets age-related disease

Gray Matter working with Insilico Medicine to identify peptide targets and accelerate development timeline...

Buck researchers provide a framework to study precision nutrigeroscience

One size doesn't fit all – a new research sub-specialty deals with the fact that health benefits from many forms of dietary restriction vary...

Accelerating antiaging research by hacking longevity

Bringing together aging researchers, developers and entrepreneurs, the Longevity Hackathon aims to build new tools, raise awareness and attract talent to the field. Kicking off...

Latest news

X marks the spot for meaningful information on aging and cognition

Understanding chromosomal differences between men and women could be the X Factor when it comes to tackling cognitive decline. A new paper published in Jama...

SENS spin-out Underdog closes $10m financing round

Underdog Pharmaceuticals, a key investment of rejuvenation biotech VC Kizoo, has closed a $10 million round of capital. Michael Greve’s Kizoo Technology Capital Group led the...

Unlocking ovarian aging could prolong fertility and delay menopause

Ovarian aging is poorly understood, under-researched and under-invested. We need a radical rethink of how we address fertility and the menopause – it's time...

Occuity raises over £2.5m for optical diabetes devices

UK MedTech firm Occuity successfully raises over £2.5m to deliver ophthalmic and optical diabetes devices and is now overfunding on Seedrs to accelerate development. DISCLOSURE:...

Fauna closes $9 million to expand drug discovery platform

Leveraging animal genomics to improve human health, Fauna Bio set to expand its comparative genomics platform for novel target drug discovery. Silicon Valley biotech startup...

Diagnostics

Occuity raises over £2.5m for optical diabetes devices

UK MedTech firm Occuity successfully raises over £2.5m to deliver ophthalmic and optical diabetes devices and is now overfunding on Seedrs to accelerate development. DISCLOSURE:...

Eyes provide early view of Alzheimer’s risk

Protein deposits in the retina and brain appear to parallel possible neurodegeneration, an insight that might lead to easier, quicker detection. Amyloid plaques are protein...

Predicting possible Alzheimer’s with nearly 100% accuracy

Researchers develop a deep learning-based method that can predict the possible onset of Alzheimer's disease from brain images with an accuracy of over 99%. Researchers...

Biotech

Peptide therapeutics company targets age-related disease

Gray Matter working with Insilico Medicine to identify peptide...

Fauna closes $9 million to expand drug discovery platform

Leveraging animal genomics to improve human health, Fauna Bio...

Smartphone-sized bioartificial kidney prototype passes key test

The Kidney Project successfully tests a prototype bioartificial kidney...

Shifting gear: startup aims to de-risk rejuvenation therapy

Shift Bioscience raising funding to develop safe cellular reprogramming...

Investment

Longevity “top of my agenda” says Silicon Valley Bank VP

Flavia Popescu-Richardson talks longevity investment and how venture debt financing can benefit early stage companies. The longevity sector is expanding with early-stage companies and, although...

“Whole-body mitochondrial transfusion” start-up lands funding

Mitrix wants to create biobanks of our “young mitochondria” that we can use to help our cells regenerate as we age. Californian start-up Mitrix this...

Harvard spin-off Cellvie Inc closes $5M seed round

Kizoo leads $5M seed round at Harvard spin-off Cellvie in pursuit of new treatment modality: Therapeutic Mitochondria Transfer (TMT). Harvard spin-off Cellvie Inc has closed...

Senolytic start-up gears up for clinical trials

Rubedo’s first target is respiratory disease, with COVID-19 expected to drive an increase in lung disease over the next 10 years.   Late last year,...

Gerostate Alpha: “Our phenotype is lifespan”

Buck Institute start-up's founders talk drug discovery, indications and raising funding. Following yesterday's introduction to Gerostate Alpha, today we continue our interview with two of...

Most popular articles

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Berberine could be longevity’s “best-kept secret”

From tackling senescence to lowering blood sugar, berberine is the supplement with a host of tricks up its sleeves. Berberine is a bioactive compound found...

Spermidine: the mind-enhancing supplement

Scientists are finding that a high intake of dietary spermidine could slow down (or reverse) the brain aging process. Memory loss and slower brain function...

Sticking with glutathione could be a smart longevity choice

The body's "master antioxidant" glutathione is a powerful weapon in the fight for longevity, but it diminishes with age; AgelessRx has a range of...

Video

Exclusive video interview: David Wood demystifies the transhumanist agenda

As Longevity moves quickly into the mainstream there are terms and legacies that some use to challenge the sector's validity: we explore what it...

The Big Picture: Covid-19 and Longevity investing

Jim Mellon, Chairman and Founder, Burnbrae Group

Video interview: talking senescence with Nina Khera

Teenage founder of Canadian start-up Biotein hunts a universal phenotype for senescent cells. As we’ve covered in the past, Biotein’s Nina Khera has a mission...

Innovation

One protein to rule them all – a central target for treating dementia

Researchers from Tokyo Medical and Dental University predict and confirm a key protein mediator of dementia in frontotemporal lobar...

Building the ovarian environment from stem cells

Researchers successfully reconstitute the ovarian follicle from mouse stem cells. Researchers led by Kyushu University have succeeded in using mouse...

Economy

Buck researchers provide a framework to study precision nutrigeroscience

One size doesn't fit all – a new research sub-specialty deals with the fact that health benefits from many forms of dietary restriction vary...

Accelerating antiaging research by hacking longevity

Bringing together aging researchers, developers and entrepreneurs, the Longevity Hackathon aims to build new tools, raise awareness and attract talent to the field. Kicking off...

Unlocking ovarian aging could prolong fertility and delay menopause

Ovarian aging is poorly understood, under-researched and under-invested. We need a radical rethink of how we address fertility and the menopause – it's time...

Impetus – getting the longevity party started

Propelling longevity research towards maximum impact, the Longevity Impetus Grants have $26m in funding to award. $26m worth of funding "towards basic research that could...
Nutriop

Supplements

Targeting cognitive decline with medical food

Mitocholine raising funding for clinical trial of nutritional compound that addresses cognitive decline by bridging the ‘brain energy gap’. DISCLOSURE: Longevity.Technology (a brand of First...

What everyone ought to know about NMN

There is a whole raft of information about longevity supplements out there, but NMN is one supplement that warrants a closer look. Check out...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

From pioneers to exploders: MitoQ is driven by research

MitoQ is a supplement that's backed by a wealth of research – and they welcome the scrutiny. Therapies and supplements often reference studies that evidence...

AI/Digital

Peptide therapeutics company targets age-related disease

Gray Matter working with Insilico Medicine to identify peptide...

Shifting gear: startup aims to de-risk rejuvenation therapy

Shift Bioscience raising funding to develop safe cellular reprogramming...

Predicting possible Alzheimer’s with nearly 100% accuracy

Researchers develop a deep learning-based method that can predict...

Agetech

Honor acquires Home Instead – big news for aging in place

Together, Honor and Home Instead plan to transform care experience for caregivers and older adults by empowering the caregiving workforce and increasing innovation to revolutionise...

Student designs smart mobility aid for dementia sufferers

New smart mobility aid will allow people with dementia to live independently for longer and reduce strain on the care system. According to Alzheimer’s Research UK,...

Senior living tech is now a must-have

K4Connect co-founder reveals how the senior living operators’ views on technology have changed since the arrival of COVID-19. Agetech company K4Connect this week unveiled a...

Huma’s $130m raise will scale its digital health platform

With the goal of bringing proactive, predictive care to all, Huma has $130 million financing from leading health and technology companies. The investment arms of...